C4 Therapeutics is a clinical-stage biopharmaceutical company focused on discovering and developing a new generation of medicines for the treatment of cancer and other diseases. They leverage their proprietary drug discovery platform to design and synthesize small molecules that selectively engage the body's protein degradation machinery to target and eliminate disease-causing proteins.